We find that compounds known to induce p53 activity such as daunorubicin via DNA damage, Nutlin-3 via HDM2 inhibition, and TSA via HDAC inhibition, all result in significant synergy with JQ1 in OCI-AML3 cells, an AML cell line with intact functional p53. Here, MDM2 is linked to acute myeloid leukemia.